Redundant and alternative roles for activating Fc receptors and complement in an anti body-dependent model of autoimmune vitiligo

被引:60
作者
Trcka, J
Moroi, Y
Clynes, RA
Goldberg, SM
Bergtold, A
Perales, MA
Ma, MH
Ferrone, CR
Carroll, MC
Ravetch, JV
Houghton, AN
机构
[1] Mem Sloan Kettering Canc Ctr, Swim Amer Lab, New York, NY 10021 USA
[2] Cornell Univ, Weill Grad Sch, New York, NY 10021 USA
[3] Columbia Univ Coll Phys & Surg, Dept Med & Microbiol, New York, NY 10032 USA
[4] Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[6] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA
关键词
D O I
10.1016/S1074-7613(02)00327-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complement and Fc receptor (FcR)-positive cells mediate effector functions of antibodies. Antibody-dependent immunity against the melanosome membrane glycoprotein gp75/tyrosinase-related protein-1 (TYRP-1) of melanocytes leads to autoimmune hypopigmentation (vitiligo) in mice. Hypopigmentation occurred in mice deficient in activating FcR containing the common gamma subunit (FcgammaR gamma(-/-)) and in mice deficient in the C3 complement component. Mice doubly deficient in both FcgammaRgamma and C3 did not develop hypopigmentation, suggesting that complement and FcgammaR formed redundant mechanisms. Following passive immunization with antibody, no further adaptive immune responses were required. Chimeric FcgammaR gamma(-/-),C3(-/-) mice reconstituted with bone marrow from either FcgammaR gamma(-/-) or C3-/- mice or adoptively transferred with FcgammaR gamma(+/-) macrophages did develop antibody-mediated hypopigmentation. Thus, either complement or macrophages expressing activating FcgammaR can independently and alternatively mediate disease in a model of autoimmune vitiligo.
引用
收藏
页码:861 / 868
页数:8
相关论文
共 40 条
[1]   A codominant role of FcγRI/III and C5aR in the reverse Arthus reaction [J].
Baumann, U ;
Köhl, J ;
Tschernig, T ;
Schwerter-Strumpf, K ;
Verbeek, JS ;
Schmidt, RE ;
Gessner, JE .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :1065-1070
[2]   Coupling and uncoupling of tumor immunity and autoimmunity [J].
Bowne, WB ;
Srinivasan, R ;
Wolchok, JD ;
Hawkins, WG ;
Blachere, NE ;
Dyall, R ;
Lewis, JJ ;
Houghton, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (11) :1717-1722
[3]   Fc receptors are required in passive and active immunity to melanoma [J].
Clynes, R ;
Takechi, Y ;
Moroi, Y ;
Houghton, A ;
Ravetch, JV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :652-656
[4]   CYTOTOXIC ANTIBODIES TRIGGER INFLAMMATION THROUGH FC-RECEPTORS [J].
CLYNES, R ;
RAVETCH, JV .
IMMUNITY, 1995, 3 (01) :21-26
[5]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[6]  
Fischer MB, 1996, J IMMUNOL, V157, P549
[7]   Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape [J].
Hahne, M ;
Rimoldi, D ;
Schroter, M ;
Romero, P ;
Schreier, M ;
French, LE ;
Schneider, P ;
Bornand, T ;
Fontana, A ;
Lienard, D ;
Cerottini, JC ;
Tschopp, J .
SCIENCE, 1996, 274 (5291) :1363-1366
[8]   IMPLICATING A ROLE FOR IMMUNE RECOGNITION OF SELF IN TUMOR REJECTION - PASSIVE-IMMUNIZATION AGAINST THE BROWN LOCUS PROTEIN [J].
HARA, I ;
TAKECHI, Y ;
HOUGHTON, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1609-1614
[9]   Impaired IgG-dependent anaphylaxis and arthus reaction in Fc gamma RIII (CD16) deficient mice [J].
Hazenbos, WLW ;
Gessner, JE ;
Hofhuis, FMA ;
Kuipers, H ;
Meyer, D ;
Heijnen, IAFM ;
Schmidt, RE ;
Sandor, M ;
Capel, PJA ;
Daeron, M ;
vandeWinkel, JGJ ;
Verbeek, JS .
IMMUNITY, 1996, 5 (02) :181-188
[10]  
Heller T, 1999, J IMMUNOL, V163, P985